Category: Heel Pharmacological Index

  • Luffa operculata-Injeel

    Luffa operculata-Injeel
    D 10, D 30, D 200 0.367 ml each.
    Luffa operculata-Injeel forte
    D 6, D 10, D 30, D 200 0.275 ml each.

    Allergic and vasomotory rhinitis, rhinitis atrophicans, sinusitis, hay fever.

  • Kalium carbonicum-Injeel

    Kalium carbonicum-Injeel
    D 12, D 30, D 200, D 1000 0.275 ml each.
    Kalium carbonicum-Injeel forte N
    D 6, D 12, D 30, D 200, D 1000 0.220 ml each.

    Remedy for debility, back pains between the shoulder blades, arrhythmia cordis, myocardial damage, oedema of the upper eylids, tendency toward sudoresis.

  • Toxoplasmose-Nosode-Injeel

    Toxoplasmose-Nosode-Injeel
    D 15, D 30, D 200 ana partes.
    Toxoplasmose-Nosode-Injeel forte
    D 10, D 15, D 30, D 200 0.275 ml each.

    Condition after recovery from fetopathia toxoplasmotica, especially physical and mental disturbances and retardation. Symptomatically for unbearable, intractable headaches, e.g. in excessive hypertonia, migraine, mental changes, e.g. conditions of depression following chronic encephalitis, enterocolitis, hepatitis, lienitis, myositis, orchitis and a few skin diseases of the papular type (erythema nodosum).

    To be administered in general as intermediate injection in retoxic phases, e.g. when children are retarded in their development (for example, after retoxically treated influenza or angina), but also after retoxic treatment of these diseases in adulthood, however (delayed convalescence).

  • Medulla ossis suis-Injeel

    Medulla ossis suis-Injeel and forte
    (bone marrow)

    Anemia, leukemia, agranulocytosis and other therapeutical damage, radiation damage, coxitis, osteomalacia, osteomyelitis chronica, exostosis, arthritis deformans, Sudeck’s disease.

  • Carcinoma coli-Injeel

    Carcinoma coli-Injeel
    D 10, D 30, D 200 0.367 ml each.
    Carcinoma coli-Injeel forte
    D 6, D 10, D 30, D 200 0.275 ml each.

    For auxiliary/additional therapy in carcinoma of the colon (also particularly post-operatively, e.g. in cases of anus preater prosthesis). Sigmoiditis, colitis mucosa et ulcerosa.

  • Ventriculus suis-Injeel

    Ventriculus suis-Injeel and forte
    (gastric mucosa)

    Achylia gastrica, anemia perniciosa, post-infectious anemia, precancerous dermatosis of the abdomen, chronic gastric ulcers, pyrosis.

    See also Curvatura major ventriculi suis-Injeel, Curvatura minor ventriculi suis-Injeel, Cardia ventriculi suis-Injeel, Pylorus suis-Injeel.

  • Pulmonaria vulgaris-Injeel

    Pulmonaria vulgaris-Injeel
    D 10, D 30, D 200 0.367 ml each.

    Laryngitis, tracheitis, bronchitis.

  • Sutoxol-Injeel

    Sutoxol-Injeel
    D 12, D 30, D 200 0.367 ml each.
    Sutoxol-Injeel forte
    D 6, D 12, D 30, D 200 0.275 ml each.

    Serious homotoxin levels in phases of all types; to be applied, or interposed, above all for the purification of the homotoxic terrain. Tendency toward suppurations, furuncles, carbuncles, lymphatism, fluor albus, cholangitis, cholecystitis, cholelithiasis. Experimentally for chronic appendicitis; in neoplasm phases as intermediate remedy. Sutoxol-Injeel, in many respects, shows similarities with Pyrogenium-Injeel, so that it may also be applied for the Indications of Pyrogenium-Injeel.

    In addition to Insektizid-Injeel, Psorinoheel, Grippe-Nosode-Injeel, Diphtherinum-Injeel, Scarlatinum-Injeel, Adeps suillus-Injeel and Pyrogenium-Injeel, one of the most important nosodes, particularly for lowering serious homotoxin levels.

  • Hedera helix-Injeel

    Hedera helix-Injeel
    D 12, D 30, D 200 0.367 ml each.
    Hedera helix-Injeel forte
    D 4, D 12, D 30, D 200 0.275 ml each.

    Acute and chronic nasal catarrh (of the sinuses); ice-cold, moist hands (cold and clammy hands) and feet.

  • Prostata suis-Injeel

    Prostata suis-Injeel and forte
    Prostata suis
    D 6; D 200 as single potencies

    Prostatic adenoma, disturbances of micturition and potency, premature aging, marasmus and cachexia.